EAM Investors’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-68,609
Closed -$4.03M – 376
2026
Q2
$4.03M Buy
+68,609
New +$2.88M 0.36% 133
2021
Q1
– Sell
-27,449
Closed -$1.34M – 445
2020
Q4
$1.34M Sell
27,449
-9,865
-26% -$457K 0.22% 218
2020
Q3
$1.21M Buy
+37,314
New +$1.19M 0.29% 159
2019
Q4
– Sell
-89,456
Closed -$2.15M – 320
2019
Q3
$2.15M Sell
89,456
-65,325
-42% -$1.74M 0.57% 49
2019
Q2
$4.41M Sell
154,781
-41,812
-21% -$1.04M 1.08% 3
2019
Q1
$4.92M Sell
196,593
-29,328
-13% -$560K 1.21% 2
2018
Q4
$2.84M Buy
225,921
+152,081
+206% +$1.8M 0.77% 23
2018
Q3
$705K Buy
+73,840
New +$814K 0.1% 274
2017
Q3
– Sell
-50,227
Closed -$418K – 349
2017
Q2
$418K Sell
50,227
-17,784
-26% -$145K 0.07% 282
2017
Q1
$624K Buy
+68,011
New +$556K 0.1% 270
2015
Q3
– Sell
-148,324
Closed -$1.65M – 342
2015
Q2
$1.65M Buy
+148,324
New +$1.46M 0.19% 212

Other funds holding VCYT

EAM Investors's VCYT Position: Q3 2026 in Review

EAM Investors sold out of Veracyte (VCYT) in Q3 2026, closing a stake of 68,609 shares — an estimated $4.03M sold.

EAM Investors first reported a position in VCYT in Q2 2015 and held it in 11 quarters. The position peaked at $4.92M in Q1 2019. 383 funds tracked by Wall St. Rank hold VCYT as of Q3 2026.

  • EAM Investors reported no remaining Veracyte position as of Q3 2026 after selling out during the quarter.
  • EAM Investors sold 68,609 Veracyte shares in Q3 2026, an estimated $4.03M.
  • EAM Investors first reported a position in Veracyte in Q2 2015 and held it in 11 quarters.
  • EAM Investors's Veracyte position peaked at $4.92M in Q1 2019.
  • 383 funds tracked by Wall St. Rank held Veracyte as of Q3 2026.

Based on EAM Investors's 13F filing for Q3 2026, filed 16 Nov 2026.